MLE-4901 is primarily utilized in the field of medical research, particularly in the study of cardiovascular diseases. It acts as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH), which plays a significant role in regulating inflammation and blood pressure. By inhibiting sEH, MLE-4901 helps to increase the levels of epoxyeicosatrienoic acids (EETs), bioactive lipids that promote vasodilation, reduce inflammation, and protect against tissue damage. This makes it a promising candidate for developing therapies aimed at treating hypertension, heart failure, and other conditions related to vascular dysfunction. Additionally, its anti-inflammatory properties are being explored for potential applications in managing chronic inflammatory diseases and pain relief.